Product scopeextension
350 MILLION PEOPLE SUFFER FROM GENETIC DISEASES WORLDWIDE, 75% OF THEM CHILDREN.
Source: Institut Imagine.
INCLUSION
FRANCE, EUROPE
SUPPORTING MEDICAL RESEARCH ON GENETIC-RELATED DISEASES AND FUELLING THE EVOLUTION OF INSURANCE PRODUCTS
BNP Paribas Cardif has become a partner of Institut Imagine, Europe’s leading centre for research on genetic diseases. Through this philanthropy partnership, the insurer actively supports research and helps support the discovery of breakthroughs for innovative therapeutic approaches. Built around sharing of expertise, this partnership also provides input to guide changes in insurance products and pricing.
Rare diseases affect under one out of 2,000 people and 80% are due to genetic disorders. Some three million people in France suffer from these diseases. It is extremely challenging for patients to obtain an initial diagnosis and then access to treatment. Thousands of families have to wait up to four or five years before the disease is diagnosed. Institut Imagine is the first European centre dedicated to the needs of these families and their children, bringing together over 1,000 researchers, physicians and engineers to expand knowledge and identify new therapeutic approaches. Thanks to this three-year philanthropy partnership, BNP Paribas Cardif has become a benefactor of the Springboard programme, an accelerator for startups dedicated to genetic diseases.
In addition to support for research, this partnership centres on expertise sharing between the two organisations. Pursuing its mission of making insurance more accessible, BNP Paribas Cardif draws on its relationship with Institut Imagine to improve its knowledge of genetic disease and the needs of families. These invaluable insights and continuing input will help the insurer introduce changes to its product offering and coverage, taking into account medical advances in order to better address the needs of customers. The initiative also includes outreach targeting staff, partners and policyholders to heighten awareness of genetic disorders and encourage philanthropy actions.
INSTITUT IMAGINE
The Institut Imagine is Europe’s leading research and teaching centre dedicated to genetic diseases. On its campus at Hôpital Necker-Enfants malades in Paris, 1,000 researchers, physicians and engineers, 28 research teams and 17 advanced technology platforms join forces to address this urgent public health issue, which affects over three million people in France. The Institute pursues its two-fold objective of diagnosis and cure thanks to the support of six founding members and the backing of the private sector and benefactors.